Rafael Bejar
Aptose Biosciences Inc. · UCSD
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Rafael Bejar as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 03:37 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT04477291 · A Study of CG-806 in Patients With Relapsed or Refractory AML or Higher-Risk MDSAptose Biosciences Inc. · terminated · Acute Myeloid Leukemia, Myelodysplastic Syndromes · study director
- Ph1NCT03893682 · A Study of CG-806 in Patients With Relapsed or Refractory CLL/SLL or Non-Hodgkin's LymphomasAptose Biosciences Inc. · terminated · Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Non-Hodgkin's Lymphoma · study director
- N/ANCT03072498 · Collection of Samples From Patients With MDSPersImmune, Inc · unknown · Myelodysplastic Syndromes(MDS) · principal investigator
- Ph1NCT02267863 · A Study of APTO-253 in Patients With Relapsed or Refractory AML or MDSAptose Biosciences Inc. · terminated · Acute Myelogenous Leukemia in Relapse, Acute Myelogenous Leukemia, Relapsed, Adult, Acute Myelogenous Leukemia, Adult · study director
Grants
NIH projects from RePORTER, fetched 2026-11-12 03:37 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 2 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 03:37 UTC. The ranking covers the 200 most relevant of 5 PubMed records, and a shared surname and initials can bring in a namesake. All 5 on PubMed
- 46 citationsRCR 2.2
- Controlled study of the effects of indomethacin on cerebral blood flow velocities in newborn infants.J Pediatr · 199134 citationsRCR 2.2
- Effects on cerebral blood flow velocities of slow and rapid infusion of indomethacin.J Perinatol · 19948 citationsRCR 0.4
- Preclinical Development of Tuspetinib for the Treatment of Acute Myeloid Leukemia.Cancer Res Commun · 20254 citationsRCR 1.0
- 1 citationsRCR 0.2